Volatility Isn’t the Risk You Should Fear — These Are

Photo of Ian Cooper
By Ian Cooper Published

Quick Read

  • HD carries $20B in debt due this year against $1B in cash, and JNJ's STELARA lost 60% to biosimilars. Neither risk shows up in a red trading day.

  • PG absorbed a $400M tariff hit and margin compression while MSFT dropped 20% despite 40% Azure growth, and in both stories the driving factor is execution risk rather than volatility.

  • Sather warns that even Buffett let positions run to 40% of his portfolio, moves that build wealth but wreck it just as fast.

  • This lithium producer surpassed a $1B private valuation, joining some of America's most powerful startups. Now you can invest in EnergyX alongside global giants like General Motors, but only through July 16. (sponsor)

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Volatility Isn’t the Risk You Should Fear — These Are

© Atichat Wattanasin Stone / Shutterstock.com

On the July 6 episode of The Investing for Beginners Podcast, hosts Andrew Sather and Stephen Morris pushed back on a common instinct among retail investors: treating a red day as the definition of risk. Sather framed volatility as “temporary pain,” the price of admission for compounding.

He also pointed instead to what he calls permanent damage: impairments, inflation, erosion, forced selling, and liquidity risk. His oxygen analogy captures the point: “It’s like oxygen, you know, like you’re not thinking about the oxygen, but as soon as it’s gone, that’s when you need it the most.”

Four large-cap stocks that investors have long viewed as defensive investments fall squarely into those categories.

Home Depot: Liquidity and the Housing Cycle

Sather’s on-air checklist for liquidity begins with the quick ratio and current ratio, then extends to disclosed credit levers like a revolver or commercial paper program. His example: if Home Depot has $7 billion due in the next 12 months but can pull $20 billion from a commercial paper program, that is a green light.

Home Depot (NYSE: HD | HD Price Prediction) ended the fiscal year with $20.28 billion in current liabilities, including short-term obligations, against $1.39 billion in cash and a current ratio of 1.06x. The company beat estimates last quarter with adjusted EPS of $2.72 versus the $2.52 consensus. CEO Ted Decker guided for FY2026 comparable sales growth of flat to 2.0%. Shares are down just 1.17% over the past year—a rounding error compared with the housing-cycle risk that ultimately drives the business.

Johnson & Johnson: When the Patent Cliff Becomes Permanent

Johnson & Johnson (NYSE:JNJ) shows the difference between a price wobble and structural impairment. A beta of 0.235 suggests the shares have historically been far less sensitive to broad market swings. Meanwhile, STELARA revenue fell 59.7% year over year to $656 million as biosimilar competition eroded the franchise. The rest of the portfolio more than offset the decline: Q1 2026 revenue rose 9.9% to $24.06 billion, prompting management to raise FY2026 sales guidance to $100.3 billion-$101.3 billion. See the Q1 2026 Form 8-K for segment detail. Biosimilar erosion is a recurring headwind that must be offset by growth from products such as TREMFYA (up 68.3% year over year) and DARZALEX (up 22.5%), or it will weigh on earnings over time.

Procter & Gamble: Inflation and Tariffs Bite the Margin

Procter & Gamble (NYSE: PG) illustrates the inflation and cost-shock bucket. Management expects roughly a $400 million after-tax tariff headwind and a $150 million commodity cost headwind in FY2026, contributing to a 100-basis-point decline in core gross margin. The balance sheet provides ample capacity to absorb the pressure, with $135.4 billion in retained earnings and $54.5 billion in shareholders’ equity as of the March 2026 quarter, alongside the company’s 70th consecutive annual dividend increase. With a beta of 0.38, the stock has historically been much less volatile than the broader market. Ultimately, purchasing power at the consumer level will determine whether volume growth returns.

Microsoft: Execution Risk Behind the Capex

Microsoft (NASDAQ: MSFT) is the stock where long-term execution matters more than short-term price swings. Shares are down 19.85% over the past year even as fiscal Q3 EPS of $4.27 beat the $4.07 consensus estimate, and Azure revenue grew 40%.

CEO Satya Nadella said the company’s AI business surpassed a $37 billion annual revenue run rate, up 123% year over year, as Microsoft invested $30.88 billion in capital expenditures during the quarter to expand its AI infrastructure. The key question for long-term investors is whether Microsoft’s $627 billion commercial remaining performance obligation and massive AI infrastructure investment translate into returns that exceed the cost of that buildout.

The Concentration Trap

Sather and Morris closed on the risk most subscribers are underweight: portfolio concentration.

They noted that even Warren Buffett let American Express run to roughly 40% of his portfolio, and repeated the trick with Coca-Cola and Apple, moves that “build wealth, but wreck it just as fast, if not faster.”

The full walkthrough of the margin-of-safety framework, including quick-ratio thresholds and credit-lever checks, is posted in the show notes at einvestingforbeginners.com. Quality diversification only works when each name’s structural risk is understood, priced, and sized accordingly.

Contact [email protected] for any questions or corrections.

Photo of Ian Cooper
About the Author Ian Cooper →

Ian Cooper is a veteran market analyst and investment strategist with more than 20 years of experience covering stocks, commodities, and macro trends. Since 1999, he has helped investors identify market opportunities using a blend of technical analysis, fundamental research, and market sentiment.

He is the creator of the ADD News Flow Strategy, which focuses on trading market reactions to major news events and investor psychology. Cooper was also among the analysts who warned about the 2008 financial crisis and major financial institution collapses ahead of the broader market.

Before joining 247 Wall St., Cooper wrote extensively for InvestorPlace and other financial publications, covering market trends, trading strategies, and investment opportunities.

Continue Reading

Top Gaining Stocks

META Vol: 40,760,422
KMX Vol: 2,288,021
WY Vol: 6,523,553
SBAC Vol: 1,443,801
NVDA Vol: 148,249,982

Top Losing Stocks

MRNA Vol: 9,176,778
CTRA Vol: 73,319,495
CRWD Vol: 9,269,567
DDOG Vol: 5,135,556
EPAM Vol: 1,164,561